Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats

Circulation Research

Volumn 110, Issue 10, 2012, Pages 1345-1354

  Yue, Jessica T Y ^a,b   Mighiu, Patricia I ^a,b   Naples, Mark ^c   Adeli, Khosrow ^b,c   Lam, Tony K T ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

CNS; glycine; hepatic lipid metabolism; NMDA receptors; obesity

Indexed keywords

7 CHLOROKYNURENIC ACID; ADENOVIRUS VECTOR; DIZOCILPINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID; SHORT HAIRPIN RNA; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; CONTINUOUS INFUSION; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HYPOTHALAMUS; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; VAGOTOMY; VAGUS NERVE DORSAL NUCLEUS;

EID: 84861101892     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.268276     Document Type: Article

References (42)

1. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993;92:141-146. (Pubitemid 23208989)
2. Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation. 2002;106: 2137-2142. (Pubitemid 35192822)
3. Gill JM, Brown JC, Bedford D, Wright DM, Cooney J, Hughes DA, Packard CJ, Caslake MJ. Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects. Atherosclerosis. 2004;176:49-56. (Pubitemid 39078644)
4. Duez H, Lamarche B, Valero R, Pavlic M, Proctor S, Xiao C, Szeto L, Patterson BW, Lewis GF. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation. 2008;117:2369-2376. (Pubitemid 351653555)
5. Pavlic M, Xiao C, Szeto L, Patterson BW, Lewis GF. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids. Diabetes. 2010;59:580-587.
6. van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, Pijl H. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes. 2004;53:2529-2534. (Pubitemid 39299258)
7. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schurmann A, Szanto I, Tschop MH, Rohner-Jeanrenaud F. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006;116:1983-1993. (Pubitemid 44033322)
8. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Bruning JC. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118:2132-2147. (Pubitemid 351872332)
9. Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD. Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes. 2008;57:1482-1490.
10. Lam TK. Neuronal regulation of homeostasis by nutrient sensing. Nat Med. 2010;16:392-395.
11. Purkayastha S, Zhang G, Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat Med. 2011;17:883-887.
12. Lam TK, Gutierrez-Juarez R, Pocai A, Bhanot S, Tso P, Schwartz GJ, Rossetti L. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med. 2007;13:171-180.
13. Lam TK, Schwartz GJ, Rossetti L. Hypothalamic sensing of fatty acids. Nat Neurosci. 2005;8:579-584. (Pubitemid 40594197)
14. Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, Patterson JT, Grant E, Wilson-Perez HE, Granholm NA, Arnold M, Trevaskis JL, Butler AA, Davidson WS, Woods SC, Benoit SC, Sleeman MW, DiMarchi RD, Hui DY, Tschop MH. Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci. 2010;13: 877-882.
15. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM, Howles PN, Morgan DA, Benoit SC, Szanto I, Schrott B, Schurmann A, Joost HG, Hammond C, Hui DY, Woods SC, Rahmouni K, Butler AA, Farooqi IS, O'Rahilly S, Rohner-Jeanrenaud F, Tschop MH. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest. 2007;117:3475-3488. (Pubitemid 350097003)
16. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Harvey-White J, Schwartz GJ, Kunos G, Rossetti L. Leptin controls adipose tissue lipogenesis via central, STAT3- independent mechanisms. Nat Med. 2008;14:667-675. (Pubitemid 351809549)
17. Lin J, Choi YH, Hartzell DL, Li C, Della-Fera MA, Baile CA. CNS melanocortin and leptin effects on stearoyl-CoA desaturase-1 and resistin expression. Biochem Biophys Res Commun. 2003;311:324-328. (Pubitemid 37340080)
18. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005;307:1909-1914. (Pubitemid 40404693)
19. Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 2009;10:99-109.
20. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117:13-23. (Pubitemid 46048445)
21. Coll AP, Farooqi IS, O'Rahilly S. The hormonal control of food intake. Cell. 2007;129:251-262. (Pubitemid 46574977)
22. Wang PY, Caspi L, Lam CK, Chari M, Li X, Light PE, Gutierrez-Juarez R, Ang M, Schwartz GJ, Lam TK. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature. 2008;452: 1012-1016. (Pubitemid 351589616)
23. Lam CK, Chari M, Su BB, Cheung GW, Kokorovic A, Yang CS, Wang PY, Lai TY, Lam TK. Activation of N-methyl-D-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production. J Biol Chem. 2010;285:21913-21921.
24. Lam CK, Chari M, Rutter GA, Lam TK. Hypothalamic nutrient sensing activates a forebrain-hindbrain neuronal circuit to regulate glucose production in vivo. Diabetes. 2011;60:107-113.
25. Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol. 2007;7:39-47. (Pubitemid 46238036)
26. Kawai N, Bannai M, Seki S, Koizumi T, Shinkai K, Nagao K, Matsuzawa D, Takahashi M, Shimizu E. Pharmacokinetics and cerebral distribution of glycine administered to rats. Amino Acids. 2011.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
28. -ΔΔCt Method. Methods. 2001;25: 402-408. (Pubitemid 34164012)
29. Benarroch EE. NMDA receptors: recent insights and clinical correlations. Neurology. 2011;76:1750-1757.
30. McBain CJ, Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev. 1994;74:723-760.
31. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell. 2005;120:261-273. (Pubitemid 40174768)
32. Lewis GF, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in noninsulin- dependent diabetes mellitus. Diabetes Metab Rev. 1996;12:37-56. (Pubitemid 26164838)
33. Ginsberg HN, Fisher EA. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. J Lipid Res. 2009;50(Suppl): S162-S166.
34. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36: 232-240. (Pubitemid 40755136)
35. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE. 2004;2004:re16.
36. Bergeron R, Meyer TM, Coyle JT, Greene RW. Modulation of N-methyl- D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A. 1998;95:15730-15734. (Pubitemid 29018768)
37. Baptista V, Varanda WA. Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons. J Neurophysiol. 2005;94: 147-152. (Pubitemid 40923234)
38. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 2002;415:793-798. (Pubitemid 34150501)
39. Rutledge AC, Su Q, Adeli K. Apolipoprotein B100 biogenesis: A complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly. Biochem Cell Biol. 2010;88:251-267.
40. Cartwright IJ, Higgins JA. Quantification of apolipoprotein B-48 and B-100 in rat liver endoplasmic reticulum and Golgi fractions. Biochem J. 1992;285(Pt 1):153-159.
41. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23:201-229. (Pubitemid 34299024)
42. Aust L, Poledne R, Elhabet A, Noack R. The hypolipaemic action of a glycine rich diet in rats. Nahrung. 1980;24:663-671.